Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

Historical Holders from Q3 2024 to Q3 2025

Symbol
SONN on Nasdaq
CUSIP
83548R402
Type / Class
Equity / COM NEW
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
180K
Holdings value
$224K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
9
Number of buys
5
Number of sells
-1
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 32 $147 $4.59 1
2025 Q2 180K $224K +$23.8K $1.24 9
2025 Q1 161K $216K +$86.7K $1.34 7
2024 Q4 89.1K $130K +$130K $1.46 9
2024 Q3 443 $2.96K +$2.53K $6.69 2